Daniel Robert Nethercott
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 5
-
- Neurological Complications and Syndromes 2
- Co-authors
- Nicholas Truman (1 shared paper)Iain R Crossingham (1 shared paper)Malachy O. Columb (1 shared paper)Tim Strang (1 shared paper)Piotr Krysiak (1 shared paper)
- Journals
- The Lancet (4 papers)Journal of the Intensive Care Society (3 papers)Clinical Colorectal Cancer (1 paper)Nature Communications (1 paper)The Lancet Child & Adolescent Health (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Daniel Robert Nethercott
13 papers receiving 1.3k citations
Daniel Robert Nethercott's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 1.1k
- Applied Microbiology and Biotechnology 34
- Internal Medicine 27
- Statistics and Probability 39
- Oncology 66
Countries citing papers authored by Daniel Robert Nethercott
This map shows the geographic impact of Daniel Robert Nethercott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Robert Nethercott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Robert Nethercott more than expected).
Fields of papers citing papers by Daniel Robert Nethercott
This network shows the impact of papers produced by Daniel Robert Nethercott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Robert Nethercott. The network helps show where Daniel Robert Nethercott may publish in the future.
Co-authors
The 5 scholars most cited alongside Daniel Robert Nethercott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | 2021 | 213 | |
| 5 | 2024 | 24 | |
| 6 | 2014 | 13 | |
| 7 | 2012 | 12 | |
| 8 | 2016 | 9 | |
| 9 | 2024 | 6 | |
| 10 | 2014 | 5 | |
| 11 | 2010 | 4 | |
| 12 | 2010 | 1 | |
| 13 | 2013 | 1 |
About Daniel Robert Nethercott
Daniel Robert Nethercott is a scholar working on Infectious Diseases, Psychiatry and Mental health, Speech and Hearing, Anesthesiology and Pain Medicine and Emergency Medicine, having authored 13 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Neurological Complications and Syndromes (2 papers), Tracheal and airway disorders (2 papers), Clinical Nutrition and Gastroenterology (1 paper), Ethics in medical practice (1 paper), Poisoning and overdose treatments (1 paper), Dysphagia Assessment and Management (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (34 citations), Internal Medicine (27 citations), Statistics and Probability (39 citations) and Oncology (66 citations). Daniel Robert Nethercott has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Nicholas Truman, Iain R Crossingham, Malachy O. Columb, Tim Strang and Piotr Krysiak. Their work appears in journals such as The Lancet, Journal of the Intensive Care Society, Clinical Colorectal Cancer, Nature Communications and The Lancet Child & Adolescent Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.